Nuvation Bio Inc. - NUVB
-
Commons
$1.76
+0.57%NUVB Vol: 4.1M
-
Warrants
$0.17
+3.19%NUVB+ Vol: 200.0
SPAC Stats
Market Cap: 385.1M
Average Volume: 454.5K
52W Range: $1.52 - $4.31
Weekly %: +1.15%
Monthly %: +7.98%
Inst Owners: 185
Info
π―Price Targets
Rating
Analyst Firm
Price Target
03/22/22
Outperform - $12.0
08/22/22
Buy - $4.5
π°News and PRs
Nuvation Bio Reports Second Quarter 2021 Financial Results and Provides Business Update
Nuvation Bio Appoints David C. Hanley, Ph.D., as Chief Technical Operations Officer
Nuvation Bio to Participate in the Jefferies Virtual Healthcare Conference
Nuvation Bio Reports First Quarter 2021 Financial Results and Provides Business Update
4 Stocks Seth Klarman and David Abrams Both Own
π΅Stocktwit Mentions
oaksapollo posted at 2023-06-13T03:05:01Z
@jamal_one what are you expecting from $NUVB? They're early in the development cycle but sitting on a ton of cash. They're unlikely to get meaningful efficacy data from their ongoing studies. I like the significant CEO and institutional ownership, but don't see what moves it other than an adjustment in overall biotech valuations.
jamal_one posted at 2023-06-05T17:42:48Z
$EIGR here some tickers to consider $SGMO $ADAP $NUVB $AVIR
BidaskBot posted at 2023-06-02T01:25:10Z
NuvationBio $NUVB BidaskScore is Lowered to Sold https://bidaskclub.com/news/company/2023-05-31/NUVB
risenhoover posted at 2023-06-02T00:24:36Z
$NUVB NUVB / Nuvation Bio Inc - Class A Price Target Updated https://fintel.io/sfo/us/nuvb?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget
otcdynamics posted at 2023-06-01T21:35:36Z
$NUVB Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board https://www.otcdynamics.com/nuvb-nuvation-bio-announces-formation-of-oncology-focused-scientific-advisory-board
STCKPRO posted at 2023-06-01T20:09:33Z
$NUVB NEW ARTICLE : Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board https://www.stck.pro/news/NUVB/51871253/
Stonkmoon posted at 2023-06-01T20:07:00Z
$NUVB 2023-06-01 16:05 ET Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board https://stonkmoon.com/news/NUVB/e57ba320c86e6cd285d23c969fdf73da
Quantisnow posted at 2023-06-01T20:05:51Z
$NUVB π° Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board https://quantisnow.com/i/4591329?utm_source=stocktwits 45 seconds delayed.
WebChronicleToday posted at 2023-06-01T20:05:28Z
$NUVB New Press Release: Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the formation of a Scientific Advisory Board. The Scientific Advisory Board will work alongside the Nuvation Bio management team to advance its pipeline of therapeutic candidates for some of the most difficult-to-treat cancers. βWe are proud to announce the formation of Nuvationβs Scientific Advisory Board. The six founding members are oncology drug and clinical development leaders who have advanced new therapies for various types of cancers,β said David Hung, M.D., Founder, President, and Chief Execut (...) https://webchronicletoday.com?p=364919
Stock_Titan posted at 2023-06-01T20:05:14Z
$NUVB Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board https://www.stocktitan.net/news/NUVB/nuvation-bio-announces-formation-of-oncology-focused-scientific-wqrq34mco6ff.html
yus37 posted at 2023-05-31T09:32:12Z
$XBI ...More and more biotech companies are being ignored and given no chance for their pipeline potential, despite having more funds than their market value... $ATEA Market Cap 343.61M The company has $620.69 million in cash and $2.95 million in debt, giving a net cash position of $617.74 million or $7.41 per share $VNDA Market Cap 342.37M The company has $501.50 million in cash and $8.39 million in debt, giving a net cash position of $493.11 million or $8.58 per share. $NUVB Market Cap 343.52M The company has $646.61 million in cash and $3.97 million in debt, giving a net cash position of $642.64 million or $2.94 per share. $EQ Market Cap 22.10M The company has $61.99 million in cash and $8.68 million in debt, giving a net cash position of $53.31 million or $1.55 per share
stockilluminati posted at 2023-05-25T05:53:37Z
$NUVB https://www.stockilluminati.com/nuvb/news.php - Tracking David Abrams' Abrams Capital Management Portfolio - Q1 2023 Update
BidaskBot posted at 2023-05-23T23:00:38Z
NuvationBio $NUVB BidaskScore is Upgraded to Held https://bidaskclub.com/news/company/2023-05-22/NUVB
macroaxis posted at 2023-05-18T10:14:10Z
$NUVB - Implied volatility is down to 0.0 for Nuvation Bio https://www.macroaxis.com/stock-options/NUVB/Nuvation-Bio?utm_source=dlvr.it&utm_medium=stocktwits
Quantisnow posted at 2023-05-17T21:38:54Z
$NUVB Multiple insights just appeared: 1. π SEC Form 4 filed by Blickenstaff Kim D https://quantisnow.com/i/4522529?utm_source=stocktwits 2. π SEC Form 4 filed by Falberg Kathryn E https://quantisnow.com/i/4522535?utm_source=stocktwits 3. π SEC Form 4 filed by Vernon W Anthony https://quantisnow.com/i/4522561?utm_source=stocktwits 4. π SEC Form 4 filed by Welch Daniel G https://quantisnow.com/i/4522566?utm_source=stocktwits #healthcare
fla posted at 2023-05-17T21:16:29Z
$NUVB [15s. delayed] filed SEC form 4: Director WELCH DANIEL G: Transacted Derivative Securities on 2023-05-15. https://s.flashalert.me/nAHPOU
fla posted at 2023-05-17T21:16:05Z
$NUVB [15s. delayed] filed SEC form 4: Director VERNON W ANTHONY: Transacted Derivative Securities on 2023-05-15. https://s.flashalert.me/YIgw6J
fla posted at 2023-05-17T21:14:51Z
$NUVB [15s. delayed] filed SEC form 4: Director FALBERG KATHRYN E: Transacted Derivative Securities on 2023-05-15. https://s.flashalert.me/6sZFr
fla posted at 2023-05-17T21:14:19Z
$NUVB [15s. delayed] filed SEC form 4: Director BLICKENSTAFF KIM D: Transacted Derivative Securities on 2023-05-15. https://s.flashalert.me/HB0Z4
Quantisnow posted at 2023-05-17T21:05:46Z
$NUVB π SEC Form 4 filed by Bazemore Robert B https://quantisnow.com/i/4522399?utm_source=stocktwits 45 seconds delayed.
fla posted at 2023-05-17T21:05:16Z
$NUVB [15s. delayed] filed SEC form 4: Director Bazemore Robert B: Transacted Derivative Securities on 2023-05-15. https://s.flashalert.me/7PhseZ
risenhoover posted at 2023-05-16T21:37:18Z
$NUVB / Nuvation Bio Inc - files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2023 Nuvation Bio Inc. (E https://fintel.io/sf/us/nuvb?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing
Last10K posted at 2023-05-16T20:06:56Z
$NUVB just filed with the SEC a Vote of Security Holders https://last10k.com/sec-filings/nuvb/0001193125-23-146073.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=nuvb
Quantisnow posted at 2023-05-16T20:04:40Z
$NUVB π Nuvation Bio Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders https://quantisnow.com/i/4514619?utm_source=stocktwits 45 seconds delayed.
fla posted at 2023-05-16T20:04:23Z
$NUVB [15s. delayed] filed form 8-K on May 16, 16:03:07 https://s.flashalert.me/ULtHYU
risenhoover posted at 2023-05-11T00:01:18Z
$NUVB NUVB / Nuvation Bio Inc - Class A Price Target Updated https://fintel.io/sfo/us/nuvb?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget
Ruki_ posted at 2023-05-10T19:44:55Z
$NUVB One day probably 5 years from now this will 20x + on a huge buyout
stockilluminati posted at 2023-05-08T18:37:16Z
$NUVB NUVB is scheduled to release earnings after close with EPS estimate -0.102000 and revenue estimate $0 check https://stockilluminati.com/earnings.html
Last10K posted at 2023-05-04T23:16:46Z
Last10K highlighted 24 positive and negative remarks in the $NUVB 10-Q filed today. See them in the Quarterly Report: https://last10k.com/sec-filings/NUVB/0000950170-23-017926.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=sentiment&utm_term=nuvb
Last10K posted at 2023-05-04T22:58:46Z
$NUVB just filed with the SEC a Earnings Release and a Financial Exhibit https://last10k.com/sec-filings/nuvb/0001193125-23-135935.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=nuvb
Holder Stats
1 | 0 |
---|---|
% of Shares Held by All Insider | 27.02% |
% of Shares Held by Institutions | 64.78% |
% of Float Held by Institutions | 88.77% |
Number of Institutions Holding Shares | 185 |
Mutual Fund Holders
Holder | Shares | Date Reported | Value | % Out |
---|---|---|---|---|
Fidelity Contrafund Inc | 8767264 | 2023-02-27 | 17008492 | 4.03 |
Fidelity Growth Company Fund | 5321362 | 2023-02-27 | 10323442 | 2.44 |
Vanguard Total Stock Market Index Fund | 4178976 | 2022-12-30 | 8023633 | 1.92 |
Fidelity Select Portfolios - Biotechnology | 2900326 | 2023-02-27 | 5626632 | 1.3299999999999998 |
iShares Russell 2000 ETF | 2638118 | 2023-02-27 | 5117948 | 1.21 |
Fidelity Contrafund K6 Fund | 1993505 | 2023-02-27 | 3867399 | 0.9199999999999999 |
Vanguard Small-Cap Index Fund | 1828333 | 2022-12-30 | 3510399 | 0.84 |
Vanguard Extended Market Index Fund | 1678606 | 2022-12-30 | 3222923 | 0.77 |
Fidelity Growth Company K6 Fund | 1434877 | 2023-02-27 | 2783661 | 0.66 |
Fidelity Series Growth Company Fund | 1340419 | 2023-02-27 | 2600412 | 0.62 |
Institutional Holders
Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company |
---|---|---|---|---|---|---|
2023-05-18 | JPMorgan Chase & Co. | 89,930 | $150,000 | 0.0% | +34.9% | 0.041% |
2023-05-18 | New York State Common Retirement Fund | 47,915 | $80,000 | 0.0% | -41.8% | 0.022% |
2023-05-16 | Susquehanna International Group LLP | 118,559 | $200,000 | 0.0% | +367.3% | 0.054% |
2023-05-16 | Jane Street Group LLC | 255,621 | $420,000 | 0.0% | +61.8% | 0.117% |
2023-05-16 | State Street Corp | 2,793,407 | $4,640,000 | 0.0% | +5.1% | 1.277% |
2023-05-16 | Squarepoint Ops LLC | 74,185 | $120,000 | 0.0% | +203.1% | 0.034% |
2023-05-16 | Geode Capital Management LLC | 2,388,275 | $3,970,000 | 0.0% | +3.0% | 1.092% |
2023-05-15 | Cubist Systematic Strategies LLC | 35,446 | $59,000 | 0.0% | -20.3% | 0.016% |
2023-05-15 | Wexford Capital LP | 97,638 | $160,000 | 0.0% | +324.5% | 0.045% |
2023-05-15 | Two Sigma Advisers LP | 628,200 | $1,040,000 | 0.0% | -10.5% | 0.287% |
2023-05-15 | Two Sigma Investments LP | 452,055 | $750,000 | 0.0% | -34.7% | 0.207% |
2023-05-15 | Price T Rowe Associates Inc. MD | 854,667 | $1,420,000 | 0.0% | -2.3% | 0.391% |
2023-05-15 | AXA S.A. | 371,600 | $620,000 | 0.0% | 0 | 0.170% |
2023-05-15 | Farallon Capital Management LLC | 1,465,000 | $2,430,000 | 0.0% | -30.8% | 0.670% |
2023-05-12 | Renaissance Technologies LLC | 273,100 | $450,000 | 0.0% | +89.4% | 0.125% |
2023-05-12 | AlphaCentric Advisors LLC | 345,000 | $570,000 | 0.4% | +6.2% | 0.158% |
2023-05-12 | Bank of America Corp DE | 507,452 | $840,000 | 0.0% | +66.3% | 0.232% |
2023-05-12 | HRT Financial LP | 108,463 | $180,000 | 0.0% | -67.3% | 0.050% |
2023-05-12 | UBS Group AG | 110,354 | $180,000 | 0.0% | +21,752.3% | 0.050% |
2023-05-12 | Dimensional Fund Advisors LP | 263,743 | $440,000 | 0.0% | -12.9% | 0.121% |
2023-05-12 | Charles Schwab Investment Management Inc. | 953,801 | $1,580,000 | 0.0% | +7.4% | 0.436% |
2023-05-11 | FMR LLC | 32,670,482 | $54,230,000 | 0.0% | +23.2% | 14.932% |
2023-05-11 | Citigroup Inc. | 37,474 | $62,000 | 0.0% | +123.7% | 0.017% |
2023-05-10 | Swiss National Bank | 258,100 | $430,000 | 0.0% | -8.5% | 0.118% |
2023-05-10 | Connor Clark & Lunn Investment Management Ltd. | 56,045 | $93,000 | 0.0% | -16.0% | 0.026% |
2023-05-09 | Tower Research Capital LLC TRC | 34,270 | $57,000 | 0.0% | +244.2% | 0.016% |
2023-05-09 | Bank of New York Mellon Corp | 455,159 | $760,000 | 0.0% | -3.0% | 0.208% |
2023-05-09 | Russell Investments Group Ltd. | 26,132 | $43,000 | 0.0% | 0 | 0.012% |
2023-05-08 | New York Life Investment Management LLC | 284,588 | $470,000 | 0.0% | 0 | 0.130% |
2023-05-04 | Intellectus Partners LLC | 181,669 | $300,000 | 0.1% | -7.4% | 0.083% |
2023-04-18 | Assenagon Asset Management S.A. | 482,233 | $800,000 | 0.0% | +83.6% | 0.220% |
2023-04-17 | Clarius Group LLC | 17,791 | $30,000 | 0.0% | 0 | 0.008% |
2023-03-23 | MetLife Investment Management LLC | 42,788 | $82,000 | 0.0% | -34.0% | 0.020% |
2023-02-16 | Alliancebernstein L.P. | 175,394 | $340,000 | 0.0% | +7.6% | 0.080% |
2023-02-15 | MetLife Investment Management LLC | 42,788 | $82,000 | 0.0% | -34.0% | 0.020% |
2023-02-15 | Virtu Financial LLC | 16,037 | $31,000 | 0.0% | 0 | 0.007% |
2023-02-15 | State of Wisconsin Investment Board | 105,524 | $200,000 | 0.0% | -6.5% | 0.048% |
2023-02-15 | Schonfeld Strategic Advisors LLC | 28,600 | $55,000 | 0.0% | -43.9% | 0.013% |
2023-02-15 | Squarepoint Ops LLC | 24,472 | $47,000 | 0.0% | -66.6% | 0.011% |
2023-02-15 | Millennium Management LLC | 543,578 | $1,040,000 | 0.0% | +227.0% | 0.249% |
2023-02-15 | Morgan Stanley | 434,894 | $840,000 | 0.0% | +116.6% | 0.199% |
2023-02-15 | Algert Global LLC | 201,477 | $390,000 | 0.0% | +28.8% | 0.092% |
2023-02-15 | Braidwell LP | 4,122,900 | $7,920,000 | 0.3% | 0 | 1.888% |
2023-02-15 | Centiva Capital LP | 13,296 | $26,000 | 0.0% | 0 | 0.006% |
2023-02-14 | Wexford Capital LP | 23,000 | $44,000 | 0.0% | 0 | 0.011% |
2023-02-14 | AWM Investment Company Inc. | 625,000 | $1,200,000 | 0.2% | +76.1% | 0.286% |
2023-02-14 | Price T Rowe Associates Inc. MD | 874,837 | $1,680,000 | 0.0% | -4.0% | 0.401% |
2023-02-14 | Susquehanna International Group LLP | 25,373 | $49,000 | 0.0% | -61.3% | 0.012% |
2023-02-14 | Two Sigma Investments LP | 691,875 | $1,330,000 | 0.0% | +30.3% | 0.317% |
2023-02-13 | Charles Schwab Investment Management Inc. | 888,126 | $1,710,000 | 0.0% | -7.8% | 0.407% |
2023-02-13 | Deutsche Bank AG | 75,570 | $150,000 | 0.0% | +59.9% | 0.035% |
2023-02-13 | Renaissance Technologies LLC | 144,200 | $280,000 | 0.0% | -44.6% | 0.066% |
2023-02-13 | The Manufacturers Life Insurance Company | 83,090 | $160,000 | 0.0% | +8.0% | 0.038% |
2023-02-13 | ExodusPoint Capital Management LP | 26,181 | $50,000 | 0.0% | 0 | 0.012% |
2023-02-13 | Credit Suisse AG | 116,195 | $220,000 | 0.0% | +37.5% | 0.053% |
2023-02-13 | Geode Capital Management LLC | 2,319,034 | $4,450,000 | 0.0% | +2.0% | 1.062% |
2023-02-13 | American Century Companies Inc. | 23,589 | $45,000 | 0.0% | +49.6% | 0.011% |
2023-02-13 | GSA Capital Partners LLP | 247,541 | $480,000 | 0.1% | +24.8% | 0.113% |
2023-02-13 | Choreo LLC | 12,994 | $29,000 | 0.0% | 0 | 0.006% |
2023-02-13 | Cornercap Investment Counsel Inc. | 119,285 | $230,000 | 0.0% | +57.1% | 0.055% |
2023-02-10 | Bank of America Corp DE | 305,186 | $590,000 | 0.0% | +49.3% | 0.140% |
2023-02-10 | Creative Planning | 19,328 | $37,000 | 0.0% | +60.0% | 0.009% |
2023-02-10 | Connor Clark & Lunn Investment Management Ltd. | 66,714 | $130,000 | 0.0% | 0 | 0.031% |
2023-02-10 | HRT Financial LP | 331,955 | $640,000 | 0.0% | 0 | 0.152% |
2023-02-09 | Dimensional Fund Advisors LP | 302,868 | $580,000 | 0.0% | -2.2% | 0.139% |
2023-02-09 | Principal Financial Group Inc. | 45,213 | $87,000 | 0.0% | +22.5% | 0.021% |
2023-02-09 | Citigroup Inc. | 16,754 | $32,000 | 0.0% | -27.9% | 0.008% |
2023-02-07 | AlphaCentric Advisors LLC | 325,000 | $620,000 | 0.6% | +51.2% | 0.149% |
2023-02-02 | SG Americas Securities LLC | 20,466 | $39,000 | 0.0% | -90.8% | 0.009% |
2023-02-02 | Gladius Capital Management LP | 19,479 | $38,000 | 0.0% | +47.3% | 0.009% |
2023-02-01 | Zurcher Kantonalbank Zurich Cantonalbank | 18,409 | $35,000 | 0.0% | +38.0% | 0.008% |
2023-01-17 | Hunter Perkins Capital Management LLC | 23,000 | $44,000 | 0.0% | +58.6% | 0.011% |
2023-01-12 | Assenagon Asset Management S.A. | 262,616 | $500,000 | 0.0% | 0 | 0.120% |
2022-12-08 | Bank of New York Mellon Corp | 440,523 | $990,000 | 0.0% | +10.0% | 0.202% |
2022-11-16 | Jane Street Group LLC | 157,182 | $350,000 | 0.0% | -18.4% | 0.072% |
2022-11-16 | BNP Paribas Arbitrage SNC | 70,447 | $160,000 | 0.0% | 0 | 0.032% |
2022-11-15 | State Street Corp | 3,070,398 | $6,880,000 | 0.0% | +4.1% | 1.406% |
2022-11-15 | Algert Global LLC | 156,367 | $350,000 | 0.0% | +319.6% | 0.072% |
2022-11-15 | Two Sigma Advisers LP | 382,200 | $860,000 | 0.0% | +222.0% | 0.175% |
2022-11-15 | Two Sigma Investments LP | 530,983 | $1,190,000 | 0.0% | +51.4% | 0.243% |
2022-11-15 | UBS Asset Management Americas Inc. | 142,374 | $320,000 | 0.0% | -10.6% | 0.065% |
2022-11-15 | Vanguard Group Inc. | 12,644,451 | $28,320,000 | 0.0% | +0.1% | 5.790% |
2022-11-15 | Prelude Capital Management LLC | 52,704 | $120,000 | 0.0% | 0 | 0.024% |
2022-11-15 | Price T Rowe Associates Inc. MD | 911,533 | $2,040,000 | 0.0% | +971.0% | 0.417% |
2022-11-15 | Ensign Peak Advisors Inc | 225,413 | $510,000 | 0.0% | -6.4% | 0.103% |
2022-11-15 | Federated Hermes Inc. | 18,254 | $41,000 | 0.0% | +261.4% | 0.008% |
2022-11-15 | Bank of New York Mellon Corp | 440,523 | $990,000 | 0.0% | +10.0% | 0.202% |
2022-11-15 | Caas Capital Management LP | 385,257 | $860,000 | 0.0% | 0 | 0.176% |
2022-11-14 | Cubist Systematic Strategies LLC | 73,193 | $160,000 | 0.0% | -76.5% | 0.034% |
2022-11-14 | Renaissance Technologies LLC | 260,515 | $580,000 | 0.0% | +201.9% | 0.119% |
2022-11-14 | Nuveen Asset Management LLC | 575,200 | $1,290,000 | 0.0% | -2.1% | 0.263% |
2022-11-14 | Hsbc Holdings PLC | 28,089 | $66,000 | 0.0% | 0 | 0.013% |
2022-11-10 | Dimensional Fund Advisors LP | 309,678 | $690,000 | 0.0% | +476.9% | 0.142% |
2022-11-08 | AlphaCentric Advisors LLC | 215,000 | $480,000 | 0.5% | 0 | 0.099% |
2022-11-07 | TD Asset Management Inc. | 52,800 | $120,000 | 0.0% | 0 | 0.024% |
2022-11-03 | The Manufacturers Life Insurance Company | 76,957 | $170,000 | 0.0% | +69.7% | 0.035% |
2022-10-31 | SG Americas Securities LLC | 223,031 | $500,000 | 0.0% | +39.7% | 0.102% |
2022-08-22 | Legal & General Group Plc | 39,168 | $130,000 | 0.0% | -10.3% | 0.018% |
2022-08-18 | Goldman Sachs Group Inc. | 145,046 | $470,000 | 0.0% | -79.8% | 0.066% |
2022-08-16 | Jane Street Group LLC | 192,581 | $620,000 | 0.0% | +690.5% | 0.088% |